市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | <5 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
预计人类胎盘蛋白市场在预测期内的复合年增长率约为 5%。胎盘蛋白在化妆品和治疗更年期的药物中的使用增加是触发人类胎盘蛋白市场增长的关键因素之一。例如，一些产品在促进收入增长的人胎盘市场，Melsmon Pharmaceuticals 正在生产用于治疗更年期的医药级胎盘。此外，Japan Bio Products 拥有治疗慢性肝炎的 Laennec，另一家公司 Alber David 拥有 Inj.Placentrex。（伤口治疗师）。
医疗保健研发投资的增加，以及在伪药中引入人胎盘蛋白，将为人胎盘蛋白市场创造有利可图的机会。
然而，长期使用人胎盘蛋白会导致皮肤干燥，从而阻碍市场。
报告范围
根据范围，人胎盘蛋白包括源自人胎盘的蛋白质，用于多种应用，如促黄体、催乳、化妆品和促生长作用。人胎盘蛋白市场按类型、应用和地理划分。
| By Type | |
| Hydrolyzed Human Placental Protein | |
| Human Placental Enzymes | |
| Others |
| By Application | |
| Tumor markers | |
| Life sciences | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
主要市场趋势
人胎盘蛋白领域护肤品有望占据重要市场份额
预计护肤产品将在预测期内主导全球人胎盘蛋白市场。这可以归因于化妆品在目标人群中的流行率上升以及更年期人群数量的增加。由于胎盘将发育中的胎儿与子宫壁连接到所有营养物质的吸收、体温调节、抵抗内部感染并产生支持怀孕的激素，这使得胎盘蛋白具有高营养，因此它进一步水解并用于许多护肤产品和护发治疗.
此外，随着全球人口老龄化的加剧，人胎盘蛋白提取物已被广泛用于抗衰老治疗，并正在推动整个市场的增长。
To understand key trends, Download Sample Report
北美预计将在市场上占有重要份额，预计在预测期内也将如此
北美预计将在全球人类胎盘蛋白市场占有重要的市场份额，这归因于该地区人口老龄化程度越来越高，更年期人口比例较高。根据美国国立卫生研究院的数据，美国每年约有 130 万女性进入更年期，其中 5% 的女性会提前绝经。这导致采用胎盘提取物治疗更年期，从而促进人类胎盘蛋白市场的增长。此外，医疗保健支出的增加和完善的医疗保健基础设施的存在也在很大程度上推动了整个区域市场的增长。
To understand geography trends, Download Sample Report
竞争格局
所研究的市场具有中等竞争力，并且在市场上运营的大多数公司都是来自不同国家的本地参与者。目前受到市场关注的一些公司包括 JAPAN BIO PRODUCTS Co., Ltd.、VWR International、Takara Bio Inc、Abcam plc、Kamiya Biomedical Co、Scripps Laboratories、Lee BioSolutions 和 elabscience。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing use of Cosmetics Products
-
4.2.2 Increasing Ageing Population
-
-
4.3 Market Restraints
-
4.3.1 Adverse Effects
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type
-
5.1.1 Hydrolyzed Human Placental Protein
-
5.1.2 Human Placental Enzymes
-
5.1.3 Others
-
-
5.2 By Application
-
5.2.1 Tumor markers
-
5.2.2 Life sciences
-
5.2.3 Others
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 JAPAN BIO PRODUCTS Co., Ltd.
-
6.1.2 VWR International
-
6.1.3 Takara Bio Inc
-
6.1.4 Abcam plc
-
6.1.5 Kamiya Biomedical Co.
-
6.1.6 Scripps Laboratories
-
6.1.7 Lee BioSolutions
-
6.1.8 elabscience
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The undefined market is studied from 2018 - 2026.
What is the growth rate of undefined?
The undefined is growing at a CAGR of <5% over the next 5 years.
Which region has highest growth rate in undefined?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in undefined?
North America holds highest share in 2021.
Who are the key players in undefined?
Takara Bio Inc, VWR International, Scripps Laboratories, Lee BioSolutions, JAPAN BIO PRODUCTS Co. are the major companies operating in undefined.
